{"id":"W2488647697","doi":"10.1016/j.leukres.2016.07.004","title":"A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Merck","keywords":"Medicine; Regimen; Tolerability; Internal medicine; Refractory (planetary science); Gastroenterology; Phases of clinical research; Adverse effect; Surgery; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002766046,0.0005311484,0.001025053,0.001080029,0.0004267708,0.00007120229,0.001346305,0.0005031613,0.0003038565],"category_scores_gemma":[0.0005891103,0.0002834749,0.0002968214,0.002220961,0.001402072,0.0003527651,0.0009120905,0.002406596,0.0001712015],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01374148,"about_ca_system_score_gemma":0.007502311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001059742,"about_ca_topic_score_gemma":0.0003307558,"domain_scores_codex":[0.9909375,0.0008097442,0.001158776,0.001145284,0.004003928,0.001944773],"domain_scores_gemma":[0.9947959,0.0006358171,0.0003271788,0.002240106,0.001389462,0.0006116066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6011268,0.009443798,0.03982377,0.0006787429,0.001095317,0.0007618985,0.002548934,0.00000615702,0.2224881,0.0008219584,0.03578683,0.08541764],"study_design_scores_gemma":[0.8265563,0.02773912,0.02620374,0.001841985,0.0002024306,0.00004238317,0.0002432865,0.00006114173,0.09369332,0.0002563181,0.02235777,0.0008021697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904112,0.00009790483,0.00001258232,0.001089682,0.0003007763,0.005224436,0.0001259572,0.00006606423,0.00267135],"genre_scores_gemma":[0.9915875,0.0001058755,0.0001590013,0.00007976078,0.0005936485,0.0005106194,0.00007531887,0.000139766,0.006748578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2254295,"threshold_uncertainty_score":0.9999617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05038255470315886,"score_gpt":0.3669708376196864,"score_spread":0.3165882829165275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}